IBS and Hemorrhoids
Posted , 4 users are following.
I've been diagnosed with IBS for a year now and I have a few bad flare ups a year. This last few weeks with my last flare up, I have had the worst hemorrhoids. Sitting is the worst but being up and about is not too bad. With it being Christmas it's been difficult to get an appointment with the doctors but tomorrow I'm going to insist in being seen. I just haven't experienced it so bad this time and my gut health has been troublesome with IBS and even with clean eating I still seem to suffer. So just seeing if you get hemorrhoids with an IBS flare and what you do to treat them. Over the counter suppositories have given me little relief so far.
0 likes, 7 replies
clarissa42245 sabab172
Posted
I have irritable bowel syndrome and I hate it so much I get sick all the time and if I eat I get sick and have a very bad flare up I hate it so much
sabab172 clarissa42245
Posted
It's certainly a very horrible thing to have... 😦
clarissa42245 sabab172
Posted
yea it is
pippa58442 sabab172
Posted
Have you tried ointment for your haemorroids and a stool softener to make your stools easier to pass?
sabab172 pippa58442
Posted
Yep tried the over the counter suppositories and ointment and no different. I think it's going to be a doctors visit tomorrow as its been ten days of suffering...
pippa58442 sabab172
Posted
Try ice first to see if the haemorroids shrink. My mum tried this for piles and it worked. Your doctor may be able to give you a stronger ointment and a stool softener.
maria47829 sabab172
Posted
it really is the worst. i have been watching this new medication in the US:
A new drug to treat irritable bowel syndrome with constipation (IBS-C) called tenapanor (IBSRELA) will soon be on the market.
The US Food and Drug Administration gave the green light to Ardelyx for the 50 mg, twice daily oral pill to increase bowel movements and decrease abdominal pain for IBS-C patients.
"IBSRELA has the potential to provide IBS-C patients and their doctors with a novel mechanism and an innovative approach to managing IBS-C, a highly burdensome and difficult-to-treat condition affecting more than 11 million people in the United States," Mike Raab, president and chief executive officer of Ardelyx, said in a statement. "This approval is an extremely important and rewarding milestone for Ardelyx, and represents the culmination of years of dedication to advancing our discoveries and medicines in an effective and rigorous manner.”